Sight Sciences (SGHT) Scheduled to Post Quarterly Earnings on Thursday

Sight Sciences (NASDAQ:SGHT) is set to issue its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Sight Sciences has set its FY 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.

Sight Sciences (NASDAQ:SGHT) last announced its quarterly earnings results on Thursday, March 7th. The company reported ($0.22) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.13. Sight Sciences had a negative net margin of 68.53% and a negative return on equity of 41.94%. The business had revenue of $18.75 million during the quarter, compared to analysts’ expectations of $18.70 million. During the same period last year, the business earned ($0.35) earnings per share. On average, analysts expect Sight Sciences to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Sight Sciences Price Performance

Shares of SGHT opened at $5.62 on Thursday. Sight Sciences has a 1-year low of $1.04 and a 1-year high of $11.20. The stock has a market cap of $278.47 million, a PE ratio of -4.93 and a beta of 2.83. The firm has a 50-day simple moving average of $4.92 and a two-hundred day simple moving average of $4.11. The company has a debt-to-equity ratio of 0.26, a current ratio of 13.29 and a quick ratio of 12.65.

Insider Activity at Sight Sciences

In related news, CEO Paul Badawi sold 12,571 shares of Sight Sciences stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $5.08, for a total value of $63,860.68. Following the completion of the transaction, the chief executive officer now owns 5,750,729 shares in the company, valued at $29,213,703.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Alison Bauerlein sold 10,123 shares of Sight Sciences stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $5.08, for a total value of $51,424.84. Following the completion of the transaction, the chief financial officer now owns 426,248 shares in the company, valued at $2,165,339.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Paul Badawi sold 12,571 shares of Sight Sciences stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $5.08, for a total transaction of $63,860.68. Following the completion of the transaction, the chief executive officer now owns 5,750,729 shares of the company’s stock, valued at approximately $29,213,703.32. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,129 shares of company stock worth $173,375. Corporate insiders own 27.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reiterated a “hold” rating on shares of Sight Sciences in a research report on Wednesday, April 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Sight Sciences presently has a consensus rating of “Hold” and an average price target of $4.60.

Sight Sciences Company Profile

Sight Sciences, Inc, an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork.